Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial (vol 16, pg 31, 2016)

被引:0
|
作者
Tapia, M. D.
Sow, S. O.
Lyke, K. E.
机构
来源
LANCET INFECTIOUS DISEASES | 2016年 / 16卷 / 01期
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:16 / 16
页数:1
相关论文
共 50 条
  • [21] Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial
    Low, Jenny G.
    Sung, Cynthia
    Wijaya, Limin
    Wei, Yuan
    Rathore, Abhay P. S.
    Watanabe, Satoru
    Tan, Boon Hian
    Toh, Liying
    Chua, Lion Tee
    Hou, Yan'an
    Chow, Angelia
    Howe, Shiqin
    Chan, Wing Ki
    Tan, Kah Hin
    Chung, Jasmine S.
    Cherng, Benjamin P.
    Lye, David C.
    Tambayah, Paul A.
    Ng, Lee Ching
    Connolly, John
    Hibberd, Martin L.
    Leo, Yee Sin
    Cheung, Yin Bun
    Ooi, Eng Eong
    Vasudevan, Subhash G.
    LANCET INFECTIOUS DISEASES, 2014, 14 (08): : 706 - 715
  • [22] Safety and immunogenicity of the rVSVΔG-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study
    Heppner, D. Gray, Jr.
    Kemp, Tracy L.
    Martin, Brian K.
    Ramsey, William J.
    Nichols, Richard
    Dasen, Emily J.
    Link, Charles J.
    Das, Rituparna
    Xu, Zhi Jin
    Sheldon, Eric A.
    Nowak, Teresa A.
    Monath, Thomas P.
    LANCET INFECTIOUS DISEASES, 2017, 17 (08): : 854 - 866
  • [23] Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
    Knop, Filip K.
    Aroda, Vanita R.
    do Vale, Ruben D.
    Holst-Hansen, Thomas
    Laursen, Peter N.
    Rosenstock, Julio
    Rubino, Domenica M.
    Garvey, W. Timothy
    LANCET, 2023, 402 (10403): : 705 - 719
  • [24] Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial
    Adegnika, Ayola A.
    de Vries, Sophia G.
    Zinsou, Frejus J.
    Honkepehedji, Yabo J.
    Agobe, Jean-Claude Dejon
    Vodonou, Kafui G.
    Bikangui, Rodrigue
    Hounkpatin, Aurore Bouyoukou
    Bache, Emmanuel B.
    Loembe, Marguerite Massinga
    van Leeuwen, Remko
    Molemans, Marjan
    Kremsner, Peter G.
    Yazdanbakhsh, Maria
    Hotez, Peter J.
    Bottazzi, Maria Elena
    Li, Guangzhao
    Bethony, Jeffrey M.
    Diemert, David J.
    Grobusch, Martin P.
    LANCET INFECTIOUS DISEASES, 2021, 21 (02): : 275 - 285
  • [25] Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial
    Taniguchi, Cullen M.
    Frakes, Jessica M.
    Aguilera, Todd A.
    Palta, Manisha
    Czito, Brian
    Bhutani, Manoop S.
    Colbert, Lauren E.
    Jaoude, Joseph Abi
    Bernard, Vincent
    Pant, Shubham
    Tzeng, Ching-Wei D.
    Kim, Dae Won
    Malafa, Mokenge
    Costello, James
    Mathew, Geena
    Rebueno, Neal
    Koay, Eugene J.
    Das, Prajnan
    Ludmir, Ethan B.
    Katz, Matthew H. G.
    Wolff, Robert A.
    Beddar, Sam
    Sawakuchi, Gabriel O.
    Moningi, Shalini
    Tidwell, Rebecca S. Slack
    Yuan, Ying
    Thall, Peter F.
    Beardsley, Robert A.
    Holmlund, Jon
    Herman, Joseph M.
    Hoffe, Sarah E.
    LANCET ONCOLOGY, 2023, 24 (12): : 1387 - 1398
  • [26] Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial
    Satti, Iman
    Meyer, Joel
    Harris, Stephanie A.
    Thomas, Zita-Rose Manjaly
    Griffiths, Kristin
    Antrobus, Richard D.
    Rowland, Rosalind
    Ramon, Raquel Lopez
    Smith, Mary
    Sheehan, Sharon
    Bettinson, Henry
    McShane, Helen
    LANCET INFECTIOUS DISEASES, 2014, 14 (10): : 939 - 946
  • [27] Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial (vol 31, pg 639, 2025)
    Wang, Yeming
    Wang, Hong
    Zhang, Yu
    Ma, Anlin
    Liu, Dong
    Li, Xiaoguang
    Yang, Guoru
    Deng, Min
    Wang, Shaofang
    Liu, Yuanyuan
    Liu, Chuanmiao
    Ge, Fangqi
    Wang, Sikui
    Yu, Yunsong
    Feng, Ganzhu
    Xiao, Zuke
    Li, Xing
    Sun, Yilan
    Chen, Xuyan
    Cao, Zhaolong
    Ding, Yan
    Wu, Xiaoping
    Wei, Jun
    Cao, Bin
    NATURE MEDICINE, 2025, 31 (03) : 1038 - 1038
  • [28] Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial (vol 397, pg 2070, 2021)
    Rovin, B. H.
    Teng, Y. K. O.
    Ginzler, E. M.
    LANCET, 2021, 397 (10289): : 2048 - 2048
  • [29] Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial
    Huang, Shoujie
    Zhang, Xuefeng
    Su, Yingying
    Zhuang, Chunlan
    Tang, Zimin
    Huang, Xingcheng
    Chen, Qi
    Zhu, Kongxin
    Hu, Xiaowen
    Ying, Dong
    Liu, Xiaohui
    Jiang, Hanmin
    Zang, Xia
    Wang, Zhongze
    Yang, Changlin
    Liu, Donglin
    Wang, Yijun
    Tang, Quan
    Shen, Wentong
    Cao, Huanhuan
    Pan, Huirong
    Ge, Shengxiang
    Huang, Yue
    Wu, Ting
    Zheng, Zizheng
    Zhu, Fengcai
    Zhang, Jun
    Xia, Ningshao
    LANCET, 2024, 403 (10429): : 813 - 823
  • [30] Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial
    Zhu, Feng-Cai
    Hou, Li-Hua
    Li, Jing-Xin
    Wu, Shi-Po
    Liu, Pei
    Zhang, Gui-Rong
    Hu, Yue-Mei
    Meng, Fan-Yue
    Xu, Jun-Jie
    Tang, Rong
    Zhang, Jin-Long
    Wang, Wen-Juan
    Duan, Lei
    Chu, Kai
    Liang, Qi
    Hu, Jia-Lei
    Luo, Li
    Zhu, Tao
    Wang, Jun-Zhi
    Chen, Wei
    LANCET, 2015, 385 (9984): : 2272 - 2279